Literature DB >> 20397259

Chemokines and hepatocellular carcinoma.

Fan Huang1, Xiao-Ping Geng.   

Abstract

Chemokines play a paramount role in tumor progression. In hepatocellular carcinoma (HCC) progression, chemokines and their receptors play an intricate role. Currently, chemokines and their receptors such as the CXCL12-CXCR4 axis, CX3CL1-CX3CR1 axis and the CCL20-CCR6 axis have received much research attention. Although a large number of studies show that these axes are strongly associated with HCC, the exact mechanism by which these axes promote the growth and progression of HCC remains unknown. In this paper, several chemokines and their receptor interactions in HCC progression, growth and metastasis and immune response to HCC are reviewed.

Entities:  

Keywords:  Chemokines; Hepatocellular carcinoma

Mesh：

Substances：

Year:  2010        PMID： 20397259      PMCID： PMC2856822          DOI： 10.3748/wjg.v16.i15.1832

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  30 in total

1.  Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.

Authors:  Haiying Chu; Huimin Zhou; Yanli Liu; Xinyu Liu; Yichuan Hu; Jianing Zhang
Journal:  Int J Biochem Cell Biol       Date:  2006-08-14       Impact factor: 5.085

2.  Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.

Authors:  Angela Sutton; Veronique Friand; Severine Brulé-Donneger; Thomas Chaigneau; Marianne Ziol; Odile Sainte-Catherine; Aurelie Poiré; Line Saffar; Michel Kraemer; Jany Vassy; Pierre Nahon; Jean-Loup Salzmann; Liliane Gattegno; Nathalie Charnaux
Journal:  Mol Cancer Res       Date:  2007-01       Impact factor: 5.852

3.  VCC-1, a novel chemokine, promotes tumor growth.

Authors:  Edward J Weinstein; Richard Head; David W Griggs; Duo Sun; Robert J Evans; Michelle L Swearingen; Marisa M Westlin; Richard Mazzarella
Journal:  Biochem Biophys Res Commun       Date:  2006-09-12       Impact factor: 3.575

4.  Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma.

Authors:  C Rubie; V O Frick; M Wagner; B Rau; C Weber; B Kruse; K Kempf; B Tilton; J König; M Schilling
Journal:  Scand J Immunol       Date:  2006-06       Impact factor: 3.487

5.  Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma.

Authors:  Hiroki Uchida; Yukio Iwashita; Atsushi Sasaki; Kohei Shibata; Toshifumi Matsumoto; Masayuki Ohta; Seigo Kitano
Journal:  J Gastroenterol Hepatol       Date:  2006-01       Impact factor: 4.029

6.  Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.

Authors:  Takeshi Matsubara; Takashi Ono; Akira Yamanoi; Mitsuo Tachibana; Naofumi Nagasue
Journal:  J Surg Oncol       Date:  2007-03-01       Impact factor: 3.454

7.  Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.

Authors:  Claudia Rubie; Vilma Oliveira Frick; Mathias Wagner; Christina Weber; Bianca Kruse; Katja Kempf; Jochen König; Bettina Rau; Martin Schilling
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.

Authors:  Angela Sutton; Veronique Friand; Dulce Papy-Garcia; Maylis Dagouassat; Loïc Martin; Roger Vassy; Oualid Haddad; Odile Sainte-Catherine; Michel Kraemer; Line Saffar; Gerard Yves Perret; Jose Courty; Liliane Gattegno; Nathalie Charnaux
Journal:  Mol Cancer Ther       Date:  2007-11       Impact factor: 6.261

9.  Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma.

Authors:  L Tang; H-d Hu; P Hu; Y-h Lan; M-l Peng; M Chen; H Ren
Journal:  Gene Ther       Date:  2007-06-28       Impact factor: 5.250

10.  Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes.

Authors:  Seitaro Hirano; Yukio Iwashita; Atsushi Sasaki; Seiichiro Kai; Masayuki Ohta; Seigo Kitano
Journal:  J Gastroenterol Hepatol       Date:  2007-05       Impact factor: 4.029
View more
  33 in total

Review 1.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

Review 2.  Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas.

Authors:  Antonio Solinas; Diego F Calvisi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 3.  Chemokines, chemokine receptors and the gastrointestinal system.

Authors:  Hiroshi Miyazaki; Kazuaki Takabe; W Andrew Yeudall
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

Review 4.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells.

Authors:  Yasuteru Kondo; Osamu Kimura; Yasuhito Tanaka; Masashi Ninomiya; Tomoaki Iwata; Takayuki Kogure; Jun Inoue; Masaya Sugiyama; Tatsuki Morosawa; Yasuyuki Fujisaka; Tooru Shimosegawa
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

6.  Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis.

Authors:  Olaia A Martínez-Iglesias; Elvira Alonso-Merino; Sara Gómez-Rey; Juan Pedro Velasco-Martín; Rosa Martín Orozco; Enrique Luengo; Rosa García Martín; Inmaculada Ibáñez de Cáceres; Agustín F Fernández; Mario F Fraga; Pilar González-Peramato; Constantino Varona; José Palacios; Javier Regadera; Ana Aranda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

Review 7.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

8.  The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis.

Authors:  Xiaolei Jiao; Guiming Shu; Hui Liu; Qin Zhang; Zhe Ma; Chaoyi Ren; Hongsheng Guo; Jingxiang Shi; Junguo Liu; Chuanshan Zhang; Yijun Wang; Yingtang Gao
Journal:  J Histochem Cytochem       Date:  2019-01-11       Impact factor: 2.479

Review 9.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management.

Authors:  Ken Shirabe; Takashi Motomura; Jun Muto; Takeo Toshima; Rumi Matono; Yohei Mano; Kazuki Takeishi; Hideki Ijichi; Noboru Harada; Hideaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2010-10-21       Impact factor: 3.402

10.  Mutations in BALB mitochondrial DNA induce CCL20 up-regulation promoting tumorigenic phenotypes.

Authors:  James Sligh; Jaroslav Janda; Jana Jandova
Journal:  Mutat Res       Date:  2014-11       Impact factor: 2.433
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.